Acadian Asset Management LLC Sangamo Therapeutics, Inc Transaction History
Acadian Asset Management LLC
- $28.7 Billion
- Q1 2024
A detailed history of Acadian Asset Management LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 4,943,260 shares of SGMO stock, worth $2.22 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,943,260
Previous 4,750,875
4.05%
Holding current value
$2.22 Million
Previous $2.58 Million
28.38%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding SGMO
# of Institutions
138Shares Held
100MCall Options Held
35.5KPut Options Held
65.8K-
Wasatch Advisors Inc Salt Lake City, UT20.1MShares$9.06 Million0.07% of portfolio
-
Armistice Capital, LLC New York, NY17MShares$7.63 Million0.15% of portfolio
-
Black Rock Inc. New York, NY13.3MShares$5.97 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$5.49 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.36MShares$1.51 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $70.4M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...